Day: January 19, 2022
A Novel Platform to Create Multi-Functional Immunotherapeutics for Cancer Will Feature TOBI™ Discovery Platform and Lead Product Candidate, HCW9218
MIRAMAR, Fla., Jan. 19, 2022 (GLOBE NEWSWIRE) — HCW Biologics Inc. (“HCW Biologics” or the “Company”) (NASDAQ: HCWB), a biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen health span by disrupting the link between chronic, low-grade inflammation and age-related diseases, today announced that Hing C. Wong, Ph.D., Founder and CEO of HCW Biologics, will speak at the Cambridge Healthtech Institute’s 24th Annual PepTalk Conference to be held on January 17-19, 2022 (https://www.chi-peptalk.com/protein-expression-production). The conference is taking place virtually and in person at the Hilton San Diego Bayfront in San Diego, California.
Dr. Wong’s...
Medolife Rx Submits Final Clinical Trial Data for Escozine Approval as a COVID-19 Treatment in The Dominican Republic
Written by Customer Service on . Posted in Public Companies.
BURBANK, Calif., Jan. 19, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Medolife Rx, Inc. (“Medolife”), a global integrated biopharmaceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTCQB: QNTA), announced today that the Company submitted the final clinical trial data to the Dominican Republic (“DR”) Ministry of Health (“MoH”) for approval of the Company’s product, Escozine, as a COVID-19 treatment. The product, which is registered as an alternative oncological medicine in the DR, has shown to be effective against variations of the SARS-CoV-2 virus.
After the recent meeting between Medolife CEO Dr. Mikaelian and DR Vice-President Raquel Peña de Antuña that concluded with interest from the government to register the product as a...
Shareholder Update: GSP Resource Corp. 2021 Review and 2022 Outlook
Written by Customer Service on . Posted in Public Companies.
Vancouver, British Columbia, Jan. 19, 2022 (GLOBE NEWSWIRE) — GSP Resource Corp. (TSX-V: GSPR) (FRA: 0YD) (the “Company” or “GSP”) provides shareholders with the following outlook for 2022 and review of 2021 activities. GSP’s core asset is an option to acquire a 100% interest in the past producing Alwin Copper Mine located in BC’s Highland Valley Copper Camp.
Simon Dyakowski CEO of GSP commented: “GSP had a productive year in 2021. Despite logistical challenges driven by poor weather with the Summer wildfires and Autumn flooding, GSP was able to complete approximately 2,300 meters of diamond drilling (8 holes), bringing GSP’s total drilling at the Alwin Mine Project to approximately 4,300 meters (18 holes) over the previous two exploration seasons. Other milestones achieved at Alwin last year include obtaining an important 5-year...
WISeKey Signs Agreement with Universa Blockchain to join the La Linea, Gibraltar 4th Industrial Revolution Center of Excellence
Written by Customer Service on . Posted in Public Companies.
WISeKey Signs Agreement with Universa Blockchain to join the La Linea, Gibraltar 4th Industrial Revolution Center of Excellence
Geneva, Moscow, Gibraltar, La Linea – January 19, 2022 – WISeKey International Holding Ltd (“WISeKey “) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity, AI, Blockchain and IoT company, announces the signing of a strategic partnership with Universa Blockchain.
The agreement includes deep cooperation at the La Linea Gibraltar 4th Industrial Revolution Center of Excellence (LLG 4IR).
It was created following the signing of two Memoranda of Understanding (MoUs) with Mr. Fabian Picardo, Chief Minister of Gibraltar and the Mayor of La Línea de la Concepción, Mr. Juan Franco, to spearhead innovation in the region.
The parties will unite joint efforts in the breakthrough directions of Advanced Air Mobility (AAM),...
Vodafone Turkey Selects Amdocs for Quality Engineering Transformation with Automated Agile/DevTestOps Approach
Written by Customer Service on . Posted in Public Companies.
Three-year deal will modernize Vodafone Turkey’s testing processes, delivering on operator’s digital vision for a better customer experience
JERSEY CITY, N.J., Jan. 19, 2022 (GLOBE NEWSWIRE) — Amdocs (NASDAQ: DOX), a leading provider of software and services to communications and media companies, today announced it has been selected by Vodafone Turkey to transform and automate the operator’s testing activity in line with Vodafone’s group-wide Tech 2025 modernization journey.
The three-year deal for end-to-end quality engineering services will enable Vodafone Turkey to create a next-generation quality engineering organization by establishing a Testing Center of Excellence. This will embrace an Agile/DevTestOps ‘shift-left’ approach to testing – ensuring faster time to market, improved productivity and operational efficiency. As...
Labrador Gold Announces Doubling of Drill Program to 100,000 Metres and Increase to Five Drill Rigs
Written by Customer Service on . Posted in Public Companies.
Targets entire strike length of Appleton Fault ZoneFigure 1.Gold anomalies, occurrences, and drill targets along the Appleton Fault Zone.TORONTO, Jan. 19, 2022 (GLOBE NEWSWIRE) — Labrador Gold Corp. (TSX.V:LAB | OTCQX:NKOSF | FNR: 2N6) (“LabGold” or the “Company”) is pleased to announce a significant increase to its diamond drilling program, at the 100% controlled Kingsway project near Gander, Newfoundland. This increase follows the Company’s success exploring along the Appleton Fault Zone over the past 18 months. The Kingsway project is located in the highly prospective central Newfoundland gold belt.
LabGold plans to double the current drilling program to 100,000 metres which includes the outstanding 23,000 metres remaining in the current 50,000 metre program. Four diamond drill rigs are currently operating...
VYNE Therapeutics Announces Phase 1b Data for FMX114 from Phase 1b/2a Trial for the Treatment of Mild-to-Moderate Atopic Dermatitis
Written by Customer Service on . Posted in Public Companies.
Systemic bioavailability of JAK inhibitor (tofacitinib) and S1P receptor modulator (fingolimod) in topical formulation substantially lower compared to oral equivalents
Mean Cmax of tofacitinib 50-fold and 1500-fold lower at Day 1 and 14 of study compared to the lowest commercially available oral alternative
Findings from Phase 1b safety portion of study support trial continuation
Topline Phase 2a results expected in Q1 2022
BRIDGEWATER, N.J., Jan. 19, 2022 (GLOBE NEWSWIRE) — VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”) today announced that it has completed the Phase 1b portion of a Phase 1b/2a clinical trial evaluating FMX114 for the treatment of mild-to-moderate atopic dermatitis (AD) (Study VY2021-01). FMX114 is VYNE’s proprietary investigational combination gel formulation of tofacitinib and fingolimod. The...
Oportun and Sezzle Partnering to Give Consumers More Choice in Financing Purchases
Written by Customer Service on . Posted in Public Companies.
Buy Now Pay Later leader becomes Oportun’s first digital-only Lending-as-a-Service partner
SAN CARLOS, Calif., Jan. 19, 2022 (GLOBE NEWSWIRE) — Oportun (Nasdaq: OPRT), a mission-driven fintech company, and Sezzle (ASX: SZL), a leading mission-driven Buy Now Pay Later (BNPL) solution, today announced a partnership that will provide consumers more choice when financing higher value purchases at many of Sezzle’s 44,000 online merchant partners.
“This is a significant expansion of our Lending-as-a-Service platform, and we are excited to welcome Sezzle as our first digital-only partner,” said Matt Jenkins, COO of Oportun. “Importantly, both of our companies are mission-aligned and committed to providing consumers with responsible, affordable, and transparent financing options that will help them build a credit history.”
Through the...
Xali Gold Commences Applications for Drilling Permits at El Oro, Mexico
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Jan. 19, 2022 (GLOBE NEWSWIRE) — Xali Gold Corp. (TSXV:XGC) (“Xali Gold” or the “Company”) is pleased to announce that it has started a new drilling permit application process for the 100% held El Oro gold-silver Project in Mexico.
New drill targets have been identified by using a three-dimensional (“3D”) Leapfrog model and are designed to test potential extensions to high-grade gold and silver zones intersected by previous drilling. Some of the higher grades were found in several veins with overlying lower grade disseminated gold near the Mexico-Esperanza Mines border area of the San Rafael vein.
The Mexico-Esperanza high-grade intersections at the El Oro Project include:
– 16.7g/t Au & 32.5g/t Ag over 1.4m– 30.7g/t Au & 3.0g/t Ag over 1.9m– 12.8g/t Au & 44.0g/t...
Aemetis CEO to Present to Institutional Investors at 27th Annual Credit Suisse Energy Summit Feb. 28th in Vail, Colorado
Written by Customer Service on . Posted in Public Companies.
Company to Review Recently Announced $5 Billion of Offtake Contracts for SAF and RD
CUPERTINO, CA , Jan. 19, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company focused on negative carbon intensity products, announced that Chairman and CEO Eric McAfee will provide an overview of the Aemetis Dairy RNG, Aviation Fuel, Renewable Diesel, Ethanol and Carbon Sequestration businesses at the 27th Annual Credit Suisse Energy Summit which will be held at the Grand Hyatt Vail in Vail, Colorado on February 28, 2022.
McAfee will present on the topic “$5 billion of New Contracts for Aemetis Carbon Zero Renewable Fuels: Sustainable Aviation Fuel, Renewable Diesel, Dairy RNG, Ethanol, Biodiesel, CO2 Sequestration.”
The Aemetis Carbon Zero, 90 million gallons per year,...